Bioplus Acquisition Corp Stock Profit Margin
BioPlus Acquisition Corp fundamentals help investors to digest information that contributes to BioPlus Acquisition's financial success or failures. It also enables traders to predict the movement of BioPlus Stock. The fundamental analysis module provides a way to measure BioPlus Acquisition's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BioPlus Acquisition stock.
BioPlus |
BioPlus Acquisition Corp Company Profit Margin Analysis
BioPlus Acquisition's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
CompetitionBased on the latest financial disclosure, BioPlus Acquisition Corp has a Profit Margin of 0.0%. This is 100.0% lower than that of the Capital Markets sector and about the same as Financials (which currently averages 0.0) industry. The profit margin for all United States stocks is 100.0% lower than that of the firm.
Did you try this?
Run Economic Indicators Now
Economic IndicatorsTop statistical indicators that provide insights into how an economy is performing |
All Next | Launch Module |
BioPlus Fundamentals
Return On Asset | -0.0072 | |||
Current Valuation | 215.16 M | |||
Shares Outstanding | 19.37 M | |||
Shares Owned By Insiders | 48.69 % | |||
Shares Owned By Institutions | 51.31 % | |||
Number Of Shares Shorted | 1.64 K | |||
Price To Earning | (3.62) X | |||
EBITDA | (1.17 M) | |||
Net Income | 2 M | |||
Cash And Equivalents | 294.69 K | |||
Cash Per Share | 0.01 X | |||
Total Debt | 5 M | |||
Debt To Equity | 7.23 % | |||
Current Ratio | 2.96 X | |||
Book Value Per Share | (0.86) X | |||
Cash Flow From Operations | (691.47 K) | |||
Short Ratio | 0.03 X | |||
Earnings Per Share | 0.21 X | |||
Price To Earnings To Growth | (7.93) X | |||
Target Price | 20.0 | |||
Number Of Employees | 38 | |||
Beta | 0.14 | |||
Market Capitalization | 208.98 M | |||
Total Asset | 238.32 M | |||
Retained Earnings | (14.78 M) | |||
Working Capital | 21.89 K | |||
Current Asset | 183.69 M | |||
Current Liabilities | 152.76 M | |||
Z Score | 24.97 | |||
Net Asset | 238.32 M |
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Consideration for investing in BioPlus Stock
If you are still planning to invest in BioPlus Acquisition Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BioPlus Acquisition's history and understand the potential risks before investing.
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |